State Of Wisconsin Investment Board Cure Vac N.V. Transaction History

State Of Wisconsin Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$14.73 - $35.25 $95,155 - $227,715	-6,460 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$33.72 - $48.22 $6,710 - $9,595	-199 Reduced 2.99%	6,460 $222,000
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $15,566 - $23,542	316 Added 4.98%	6,659 $364,000
Q2 2021 Aug 12, 2021	BUY	$56.91 - $127.53 $360,980 - $808,922	6,343 New	6,343 $466,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.